Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McKaylee M Robertson

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Experimental Dermatology|June 30, 2009
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERCFrancoise A Gourronc, mckaylee M Robertson, Annie K Herrig, et al.
BMJ Open|July 29, 2020
PROMISE (Program Refinements to Optimize Model Impact and Scalability based on Evidence): a cluster-randomised, stepped-wedge trial assessing effectiveness of the revised versus original Ryan White Part A HIV Care Coordination Programme for patients with barriers to treatment in the USAMary K Irvine, Bruce Levin, McKaylee M Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2018
Impact of an HIV Care Coordination Program on Durable Viral SuppressionMcKaylee M Robertson, Kate Penrose, Mary K Irvine, et al.
Annals of Epidemiology|June 25, 2026
GLP-1 Receptor Agonist Medications for Weight Loss: Sociodemographic Patterns of Awareness, Use, and Access in a U.S. National CohortJenna Sanborn, Sasha A Fleary, Denis Nash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 21, 2022
The Epidemiology of Long Coronavirus Disease in US AdultsMcKaylee M Robertson, Saba A Qasmieh, Sarah G Kulkarni, et al.
Preventive Medicine|February 22, 2023
The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, et al.
BMJ Open|July 14, 2023
Study protocol for data to suppression (D2S): a cluster-randomised, stepped-wedge effectiveness trial of a reporting and capacity-building intervention to improve HIV viral suppression in housing and behavioural health programmes in New York CityMary K Irvine, Faisal Abdelqader, Bruce Levin, et al.
American Journal of Epidemiology|May 23, 2018
Using Registry Data to Construct a Comparison Group for Programmatic Effectiveness Evaluation: The New York City HIV Care Coordination ProgramMcKaylee M Robertson, Levi Waldron, Rebekkah S Robbins, et al.
Infectious Diseases and Therapy|June 23, 2024
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US AdultsKate Penrose, Avantika Srivastava, Yanhan Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsDenis Nash, Avantika Srivastava, Jenny Shen, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Experimental Dermatology|June 30, 2009
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERCFrancoise A Gourronc, mckaylee M Robertson, Annie K Herrig, et al.
BMJ Open|July 29, 2020
PROMISE (Program Refinements to Optimize Model Impact and Scalability based on Evidence): a cluster-randomised, stepped-wedge trial assessing effectiveness of the revised versus original Ryan White Part A HIV Care Coordination Programme for patients with barriers to treatment in the USAMary K Irvine, Bruce Levin, McKaylee M Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2018
Impact of an HIV Care Coordination Program on Durable Viral SuppressionMcKaylee M Robertson, Kate Penrose, Mary K Irvine, et al.
Annals of Epidemiology|June 25, 2026
GLP-1 Receptor Agonist Medications for Weight Loss: Sociodemographic Patterns of Awareness, Use, and Access in a U.S. National CohortJenna Sanborn, Sasha A Fleary, Denis Nash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 21, 2022
The Epidemiology of Long Coronavirus Disease in US AdultsMcKaylee M Robertson, Saba A Qasmieh, Sarah G Kulkarni, et al.
Preventive Medicine|February 22, 2023
The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, et al.
BMJ Open|July 14, 2023
Study protocol for data to suppression (D2S): a cluster-randomised, stepped-wedge effectiveness trial of a reporting and capacity-building intervention to improve HIV viral suppression in housing and behavioural health programmes in New York CityMary K Irvine, Faisal Abdelqader, Bruce Levin, et al.
American Journal of Epidemiology|May 23, 2018
Using Registry Data to Construct a Comparison Group for Programmatic Effectiveness Evaluation: The New York City HIV Care Coordination ProgramMcKaylee M Robertson, Levi Waldron, Rebekkah S Robbins, et al.
Infectious Diseases and Therapy|June 23, 2024
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US AdultsKate Penrose, Avantika Srivastava, Yanhan Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsDenis Nash, Avantika Srivastava, Jenny Shen, et al.
Pageof 5